Common Specifications: An Antidote To MDR’s Clinical Evidence ‘Moveable Feast’?
Executive Summary
Unpredictable clinical evidence expectations under the new EU medtech regulations can have a chilling effect on even the most established companies, resulting in product withdrawals. Medtech Insight asked a regulatory expert how this crisis can be avoided.
You may also be interested in...
MDR Pressures: 23 Patient Groups Urge EU To Protect Pediatric And Orphan Devices
EU policymakers must implement regulatory changes targeted at devices for pediatric and rase diseases to prevent essential products from becoming unavailable to EU patients, 23 clinical organizations say in an open letter penned to the EU commissioner for health and food safety.
CAMD Says ‘Critical Appraisal’ Needed On EU MDR Capacity Bottlenecks
Yet another EU regulatory organization has stressed the need for action to address MDR capacity problems. According to CAMD, underlying factors and causes of the crisis must be identified.
Pediatric Cardiologists Told To Prepare For Critical Devices Disappearing Due To MDR
Medical devices used in pediatric heart surgeries and other products used for children and for orphan conditions may cease to be available in the EU due to the new Medical Device Regulation compounding existing market pressures, researchers have warned.